Embed Size (px)
DESCRIPTION
Procos New Generic APIS
Citation preview
PROCOS S.p.A. Via Matteotti n. 249 - 28062 CAMERI (NO) ITALY Phone: ++39-0321-642211 - Fax: ++39-0321-642219 E-mail: [email protected] www.procos.it
This list is not to be construed as a non-infringement or as an offer to sell in those countries where such would
constitute an infringement of third parties’ patent rights. September 2014
NEW PRODUCTS
VALIDATED
API CLASS/INDICATION DMF
Fampridine/Dalfampridine Treatment of some symptoms of Multiple Sclerosis EU: filed
US: available for reference
Guanfacine Antihypertensive and Treatment of ADHD EU: filed
US: filed
Iloperidone Antipsychotic EU: filed
US: available for reference
Landiolol Antiarrhythmic EU: filed
JP: filed
Lurasidone Antipsychotic EU: filed
US: in progress
Naftopidil Antihypertensive (Treatment of BPH) EU: filed
JP: filed
Ranolazine Antianginal EU: filed
US: in progress
Sivelestat Acute Respiratory Failure EU: filed
JP: filed
UNDER DEVELOPMENT
API CLASS/INDICATION DEVELOPMENT STATUS
Amifampridine Treatment of Lambert-Eaton syndrome (LEMS) LAB
Roflumilast Antiasthmatic (COPD) LAB
Silodosin Treatment of BPH KILOLAB
Agomelatine Antidepressant PILOT
Minodronic Acid Anti-osteoporosis INDUSTRIAL
UNDER EVALUATION
API CLASS/INDICATION STATUS
Alogliptin Antidiabetic Screening
Apixaban Antithrombotic Screening
Avanafil Erectyle disfunction Screening
Dapagliflozin Antidiabetic Screening
Dolutegravir HIV Screening
Droxidopa Neurogenic orthostatic hypotension Screening
Efinaconazole Onychomycosis
Screening
Levomilnacipran Major depressive disorder (MDD) Screening
Macitentan Pulmonary Arterial Hypertension (PAH) Screening
Miltefosine Leishmaniasis Screening
Perampanel Antiepileptic Screening Riociguat Pulmonary Arterial Hypertension (PAH) Screening
Simeprevir Hepatitis C Screening
Sofosbuvir Hepatitis C Screening
Vortioxetine Depressive Disorder Screening
